AKOYA BIOSCIENCES INC's ticker is AKYA and the CUSIP is 00974H104. A total of 61 filers reported holding AKOYA BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,017,748 | -49.3% | 434,935 | +1.5% | 0.00% | – |
| Q1 2024 | $2,008,854 | +15.1% | 428,327 | +19.8% | 0.00% | – |
| Q4 2023 | $1,745,044 | +4.8% | 357,591 | -0.1% | 0.00% | – |
| Q3 2023 | $1,664,807 | -23.9% | 358,023 | +20.9% | 0.00% | – |
| Q2 2023 | $2,188,844 | -2.1% | 296,190 | +8.4% | 0.00% | – |
| Q1 2023 | $2,234,850 | -56.5% | 273,209 | -49.2% | 0.00% | – |
| Q4 2022 | $5,143,434 | +87.8% | 537,454 | +130.5% | 0.00% | – |
| Q3 2022 | $2,739,000 | +6.1% | 233,121 | +16.0% | 0.00% | – |
| Q2 2022 | $2,582,000 | +28.9% | 200,936 | +10.2% | 0.00% | – |
| Q1 2022 | $2,003,000 | -15.7% | 182,291 | +17.5% | 0.00% | – |
| Q4 2021 | $2,375,000 | +59.1% | 155,097 | +45.0% | 0.00% | – |
| Q3 2021 | $1,493,000 | -5.6% | 106,979 | +30.8% | 0.00% | – |
| Q2 2021 | $1,582,000 | – | 81,780 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 4,697,785 | $22,925,191 | 20.08% |
| Parkman Healthcare Partners LLC | 674,787 | $3,292,961 | 0.46% |
| PEDDOCK CAPITAL ADVISORS, LLC | 290,720 | $1,418,714 | 0.43% |
| Uniplan Investment Counsel, Inc. | 673,523 | $3,421 | 0.25% |
| Kent Lake Capital LLC | 116,835 | $570,155 | 0.22% |
| Board of Trustees of The Leland Stanford Junior University | 620,433 | $3,027,712 | 0.20% |
| SVB WEALTH LLC | 515,317 | $2,514,747 | 0.06% |
| Polar Capital Holdings Plc | 1,579,756 | $7,709,209 | 0.05% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 126,131 | $615,519 | 0.04% |
| ZWJ INVESTMENT COUNSEL INC | 45,175 | $220,454 | 0.01% |